Ketoconazole to Reduce the Need for Cyclosporine after Cardiac Transplantation
Open Access
- 7 September 1995
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 333 (10) , 628-634
- https://doi.org/10.1056/nejm199509073331004
Abstract
Because ketoconazole can markedly reduce the need for cyclosporine and because it also has antimicrobial properties, it may offer benefits in the treatment of patients after cardiac transplantation.Keywords
This publication has 8 references indexed in Scilit:
- CYCLOSPORINE-KETOCONAZOLE INTERACTIONTransplantation, 1993
- A Preliminary Study of Diltiazem in the Prevention of Coronary Artery Disease in Heart-Transplant RecipientsNew England Journal of Medicine, 1993
- Cyclosporine and Itraconazole Interaction in Heart and Lung Transplant RecipientsAnnals of Internal Medicine, 1990
- CONCOMITANT ADMINISTRATION OF CYCLOSPORINE AND KETOCONAZOLE FOR THREE AND A HALF YEARS IN ONE HEART TRANSPLANT RECIPIENTTransplantation, 1989
- The antimycotic drug terbinafine in contrast to ketoconazole lacks acute effects on the pituitary-testicular function of healthy men: a placebo-controlled double-blind trialActa Endocrinologica, 1989
- PHARMACODYNAMICS OF CYCLOSPORINE-KETOCONAZOLE INTERACTION IN MICETransplantation, 1987
- KETOCONAZOLE-CYCLOSPORIN INTERACTIONThe Lancet, 1982
- KETOCONAZOLE, CYCLOSPORIN METABOLISM, AND RENAL TRANSPLANTATIONThe Lancet, 1982